Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 4/20 | 0.50 |
| ▸ | MTNR1B | P49286 | 4/20 | 0.50 |
| ▸ | TLR4 | O00206 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.36 |
| ▸ | KDM1A | O60341 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4420636 | 0.87 | MTNR1A (0.56) | MTNR1AMTNR1BTLR4ATMALDH1A1 | |
| Acetic Acid SCHEMBL28266825 | 0.83 | TLR4 (0.37) | MTNR1AMTNR1BTLR4ALDH1A1KDM4E | |
| SCHEMBL5949519 | 0.82 | MTNR1A (0.50) | MTNR1AMTNR1BTLR4ATMALDH1A1 | |
| SCHEMBL14720508 | 0.82 | MTNR1A (0.50) | MTNR1AMTNR1BTLR4ATMALDH1A1 | |
| SCHEMBL14274551 | 0.80 | MTNR1A (0.49) | MTNR1AMTNR1BTLR4ATMALDH1A1 | |
| SCHEMBL50350 | 0.80 | — | — | |
| SCHEMBL284319 | 0.80 | ATM (0.56) | MTNR1AMTNR1BTLR4ATMALDH1A1 | |
| SCHEMBL284342 | 0.80 | ATM (0.56) | MTNR1AMTNR1BTLR4ATMALDH1A1 | |
| SCHEMBL284318 | 0.80 | ATM (0.56) | MTNR1AMTNR1BTLR4ATMALDH1A1 | |
| SCHEMBL743138 | 0.79 | EPHX1 (0.36) | TLR4ALDH1A1KDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118325219-A | Flame-retardant cable | 中迈电线电缆有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-115029401-A | Method for co-production of fulvic acid organic fertilizer by straw sugar production | 蚌埠星河秸秆生物科技有限公司 | 2022-09-09 | — | — | CN | claimed |
| CN-115029391-A | Fermentation method for producing lactic acid by using mixed sugar as carbon source | 安徽丰原集团有限公司 | 2022-09-09 | — | — | CN | claimed |
| CN-216778796-U | Cyclization device for producing (R) -3-amino-1, 2,3, 4-tetrahydrocarbazole | 福建福瑞明德药业有限公司 | 2022-06-21 | — | — | CN | claimed |
| CN-111748048-B | Preparation method of modified chitosan acidizing corrosion inhibitor | 西南石油大学 | 2020-12-11 | — | — | CN | claimed |
| CN-111748048-A | Preparation method of modified chitosan acidizing corrosion inhibitor | 西南石油大学 | 2020-10-09 | — | — | CN | claimed |
| CN-111362884-A | Industrial preparation method of 2, 6-diamino-4, 5,6, 7-tetrahydro-benzothiazole | 江苏神龙药业股份有限公司 | 2020-07-03 | — | — | CN | claimed |
| CN-111018805-A | Synthesis and separation method of pramipexole intermediate | 江苏汉斯通药业有限公司 | 2020-04-17 | — | — | CN | claimed |
| CN-107417705-B | Imidazo [2,1-b] benzothiazole compound and its synthetic method | 湘潭大学 | 2019-07-02 | — | — | CN | claimed |
| WO-2019016828-A1 | NOVEL PROCESSES FOR THE PREPARATION OF TRANS-N-{4-[2-[4-(2,3-DICHLOROPHENYL)PIPERAZINE-1-YL]ETHYL] CYCLOHEXYL}-N',N'-DIMETHYLUREA HYDROCHLORIDE AND POLYMORPHS THEREOF | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2019-01-24 | — | — | WO | claimed |
| WO-2011021214-A2 | IMPROVED PROCESS FOR THE PREPARATION OF (S)-2-AMINO-4,5,6,7-TETRAHYDRO-6 - (PROPYLAMINO) BENZOTHIAZOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | MSN LABORATORIES LIMITED (IN) | 2011-02-24 | — | — | WO | claimed |
| WO-2008104847-A2 | PROCESSES FOR THE PREPARATION OF PRAMIPEXOLE AND SALTS THEREOF | WOCKHARDT RESEARCH CENTRE (IN) | 2008-09-04 | — | — | WO | claimed |
| EP-1562921-B1 | PROCESS FOR PREPARING 2,6-DIAMINO-4,5,6,7-TETRAHYDRO-BENZOTHIAZOLE | CIPLA LTD (IN) | 2008-05-21 | — | — | EP | claimed |
| US-7285669-B2 | Process for preparing 2,6-diamino-4,5,6,7-tetrahydro-benzothiazole | CIPLA LIMITED (IN) | 2007-10-23 | — | — | US | claimed |
| US-20060100256-A1 | Process for preparing 2,6-diamino-4,5,6,7-tetrahydro-benzothiazole | CIPLA LIMITED (IN) | 2006-05-11 | — | — | US | claimed |
| EP-1562921-A1 | PROCESS FOR PREPARING 2,6-DIAMINO-4,5,6,7-TETRAHYDRO-BENZOTHIAZOLE | Cipla Ltd. (IN) | 2005-08-17 | — | — | EP | claimed |
| WO-2004041797-A1 | PROCESS FOR PREPARING 2,6-DIAMINO-4,5,6,7-TETRAHYDRO-BENZOTHIAZOLE | CIPLA LTD (IN) | 2004-05-21 | — | — | WO | claimed |
| US-20260146043-A1 | CRYSTALLINE FORMS OF PYRIMIDINO DIAZEPINE DERIVATIVE | CYCLACEL PHARMACEUTICALS INC. (US) | 2026-05-28 | — | — | US | disclosed |
| US-3960945-A | 4-[-(Alkoxy or polyhaloalkoxy)-benzamido]cyclohexanones | STERLING DRUG INC. (US) | 1976-06-01 | — | — | US | disclosed |
| US-3959309-A | ANALGESICS, PSYCHOTROPIC, ANTIHISTAMINE | STERLING DRUG INC. (US) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260146043-A1 | CRYSTALLINE FORMS OF PYRIMIDINO DIAZEPINE DERIVATIVE | CTNND1, CCNC, SFN | MTNR1A 3144/4885MTNR1B 2186/4885TLR4 3303/4885 |
| US-20060100256-A1 | Process for preparing 2,6-diamino-4,5,6,7-tetrahydro-benzothiazole | DNPEP, DDO, HNMT | MTNR1A 3786/4885MTNR1B 2182/4885TLR4 2220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.